IL88205A0 - Novel pyridine compounds and compositions for the treatment of osteoporosis - Google Patents

Novel pyridine compounds and compositions for the treatment of osteoporosis

Info

Publication number
IL88205A0
IL88205A0 IL88205A IL8820588A IL88205A0 IL 88205 A0 IL88205 A0 IL 88205A0 IL 88205 A IL88205 A IL 88205A IL 8820588 A IL8820588 A IL 8820588A IL 88205 A0 IL88205 A0 IL 88205A0
Authority
IL
Israel
Prior art keywords
osteoporosis
compositions
treatment
pyridine compounds
novel pyridine
Prior art date
Application number
IL88205A
Other languages
English (en)
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of IL88205A0 publication Critical patent/IL88205A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL88205A 1987-10-30 1988-10-28 Novel pyridine compounds and compositions for the treatment of osteoporosis IL88205A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704248A SE8704248D0 (sv) 1987-10-30 1987-10-30 Medical use

Publications (1)

Publication Number Publication Date
IL88205A0 true IL88205A0 (en) 1989-06-30

Family

ID=20370069

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88205A IL88205A0 (en) 1987-10-30 1988-10-28 Novel pyridine compounds and compositions for the treatment of osteoporosis

Country Status (9)

Country Link
EP (1) EP0339071A1 (hu)
JP (1) JPH02501929A (hu)
KR (1) KR890701587A (hu)
AU (1) AU2620388A (hu)
DK (1) DK322189A (hu)
HU (1) HU203663B (hu)
IL (1) IL88205A0 (hu)
SE (1) SE8704248D0 (hu)
WO (1) WO1989003833A1 (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112834A (en) * 1987-07-16 1992-05-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazole protectorant for the stomach and intestine
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
WO1996034866A1 (en) * 1995-05-01 1996-11-07 Fujisawa Pharmaceutical Co., Ltd. Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors
GB9518552D0 (en) * 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New heterocyclic compounds
JP2009507032A (ja) 2005-09-02 2009-02-19 アボット・ラボラトリーズ 新規なイミダゾ系複素環
EP2655362A1 (en) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
DE102012200349A1 (de) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte annellierte Pyrimidine und Triazine und ihre Verwendung
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9776997B2 (en) 2013-06-04 2017-10-03 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-A]pyridines and their use
JP2016523944A (ja) 2013-07-10 2016-08-12 バイエル・ファルマ・アクティエンゲゼルシャフト ベンジル−１Ｈ−ピラゾロ［３，４−ｂ］ピリジンおよびその使用
CA2939793A1 (en) 2014-02-19 2015-08-27 Bayer Pharma Aktiengesellschaft 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
US9771360B2 (en) 2014-03-21 2017-09-26 Bayer Pharma Aktiengesellschaft Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use
WO2015165970A1 (de) * 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft 6-chlor-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung als stimulatoren der löslichen guanylatcyclase
CA2947374A1 (en) * 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
WO2015165931A1 (de) * 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft Imidazo[1,2-a]pyridine als stimulatoren der löslichen guanylatcyclase zur behandlung von kardiovaskulären erkrankungen
EP3227286B1 (de) 2014-12-02 2018-12-26 Bayer Pharma Aktiengesellschaft Substituierte pyrazolo[1,5-a]pyridine und imidazo[1,2-a]pyrazine und ihre verwendung
CA2969268A1 (en) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Heteroaryl-substituted imidazo[1,2-a]pyridines and their use
CA2975668A1 (en) 2015-02-05 2016-08-11 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyrazine carboxamides and use thereof
JP2018505885A (ja) 2015-02-05 2018-03-01 バイエル・ファルマ・アクティエンゲゼルシャフト 置換ピラゾロ［１，５−ａ］−ピリジン−３−カルボキサミドおよびその使用
WO2018184976A1 (de) 2017-04-05 2018-10-11 Bayer Pharma Aktiengesellschaft Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3446778A1 (de) * 1984-12-21 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
DK322189D0 (da) 1989-06-28
JPH02501929A (ja) 1990-06-28
KR890701587A (ko) 1989-12-21
SE8704248D0 (sv) 1987-10-30
HUT51138A (en) 1990-04-28
AU2620388A (en) 1989-05-23
EP0339071A1 (en) 1989-11-02
HU203663B (en) 1991-09-30
DK322189A (da) 1989-06-28
WO1989003833A1 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
IL88205A0 (en) Novel pyridine compounds and compositions for the treatment of osteoporosis
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
GB8812914D0 (en) Treatment of materials
GB8700398D0 (en) Compositions for surface treatment
ZA857081B (en) Composition for the treatment of allergy
ZA881791B (en) Therapeutic compositions
GB8713769D0 (en) Compositions of matter
IL88745A (en) Mixed compositions for treating hypercholesterolemia
GB8606468D0 (en) Therapeutic compositions
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
ZA882963B (en) New ophtalmological composition of matter
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
GB8715966D0 (en) Compositions of matter
PT85027A (en) Process for the preparation of substituted 3-amino-2-benzoylcyclohexen-2-ones and of herbicidal compositions containing them
PT84784B (en) Process for the preparation of benzoxazolyl- and benzothiazolylanilines and of fungicidal compositions containing the same
PH24312A (en) Treatment of osteoporosis
IL74373A0 (en) Process for the preparation of diaminopyridines
AR243320A1 (es) Un producto util para controlar el crecimiento de malezas en tierras de cultivo y procedimiento para prepararlo.
GB8712396D0 (en) Composition of matter
PH21642A (en) Treatment of osteoporosis
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
GB8703068D0 (en) Compositions of matter
GB8705183D0 (en) Compositions of matter
ZA889130B (en) Compositions for the reduction of phlebectasiae and process for preparing same
ZA844311B (en) Improved compositions for the treatment of psoriasis